Discordance in Biomarker Expression in Breast Cancer After Metastasis: Single Center Experience in India

PURPOSE: Biomarker—estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu) —discordance plays an essential role in the management and prognosis of patients with metastatic breast cancer. Rates of discordance have been previously reported around 12%...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Glob Oncol
Auteurs principaux: Gogia, Ajay, Deo, S. V. Suryanarayana, Sharma, Dayanand, Phulia, Rakesh K., Thulkar, Sanjay, Malik, Prabhat S., Mathur, Sandeep
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2019
Sujets:
Original Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6528736/
https://ncbi.nlm.nih.gov/pubmed/30951390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.18.00184
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires